Department of Medicine, Division of Hematology-Oncology, UCLA AIDS Institute, David Geffen School of Medicine, University of California-Los Angeles, 615 Charles E. Young Drive South, Los Angeles, CA 90095, USA.
Blood. 2010 Feb 25;115(8):1534-44. doi: 10.1182/blood-2009-04-215855. Epub 2009 Dec 17.
Inhibiting the expression of the HIV-1 coreceptor CCR5 holds great promise for controlling HIV-1 infection in patients. Here we report stable knockdown of human CCR5 by a short hairpin RNA (shRNA) in a humanized bone marrow/liver/thymus (BLT) mouse model. We delivered a potent shRNA against CCR5 into human fetal liver-derived CD34(+) hematopoietic progenitor/stem cells (HPSCs) by lentiviral vector transduction. We transplanted vector-transduced HPSCs solidified with Matrigel and a thymus segment under the mouse kidney capsule. Vector-transduced autologous CD34(+) cells were subsequently injected in the irradiated mouse, intended to create systemic reconstitution. CCR5 expression was down-regulated in human T cells and monocytes/macrophages in systemic lymphoid tissues, including gut-associated lymphoid tissue, the major site of HIV-1 replication. The shRNA-mediated CCR5 knockdown had no apparent adverse effects on T-cell development as assessed by polyclonal T-cell receptor Vbeta family development and naive/memory T-cell differentiation. CCR5 knockdown in the secondary transplanted mice suggested the potential of long-term hematopoietic reconstitution by the shRNA-transduced HPSCs. CCR5 tropic HIV-1 infection was effectively inhibited in mouse-derived human splenocytes ex vivo. These results demonstrate that lentiviral vector delivery of shRNA into human HPSCs could stably down-regulate CCR5 in systemic lymphoid organs in vivo.
抑制 HIV-1 核心受体 CCR5 的表达为控制患者体内 HIV-1 感染带来了巨大的希望。在这里,我们报告了短发夹 RNA(shRNA)在人源化骨髓/肝/胸腺(BLT)小鼠模型中稳定敲低人 CCR5 的情况。我们通过慢病毒载体转导将针对 CCR5 的强效 shRNA 递送至人胎肝来源的 CD34(+)造血祖细胞/干细胞(HPSC)。我们将转导载体的 HPSC 与 Matrigel 和胸腺节段一起固化在小鼠肾脏包膜下。随后将转导的自体 CD34(+)细胞注入辐照小鼠中,旨在进行全身重建。CCR5 表达在全身淋巴组织中的人 T 细胞和单核细胞/巨噬细胞中下调,包括肠道相关淋巴组织,这是 HIV-1 复制的主要部位。通过多克隆 T 细胞受体 Vbeta 家族发育和幼稚/记忆 T 细胞分化评估,shRNA 介导的 CCR5 敲低对 T 细胞发育没有明显的不良影响。在二次移植的小鼠中,CCR5 敲低表明转导 HPSC 的 shRNA 具有长期造血重建的潜力。在体外,CCR5 嗜性 HIV-1 感染在小鼠来源的人脾细胞中被有效抑制。这些结果表明,shRNA 可以通过慢病毒载体递送至人 HPSC 中,从而在体内稳定下调全身淋巴器官中的 CCR5。